Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christos Ermogenous
Observed name:
C Ermogenous
Institutions:
Queen Mary University of London,
Barts Cancer Institute
Observed institutions:
Queen Mary University of London,
Queen Elizabeth Hospital Birmingham,
Arthritis UK,
NIHR Surgical Reconstruction and Microbiology Research Centre,
Barts Cancer Institute,
University of Birmingham
show all 6
ORCID:
0000-0002-3397-7120
Observed ORCID:
0000-0002-3397-7120
OpenAlex ID:
A5070461208
Treating age-related multimorbidity: the drug discovery challenge
2020
·
Christos Ermogenous
, Charlotte Green
, et al.
·
Drug Discovery Today
·
38
PDF
Dysregulation of the actin scavenging system and inhibition of DNase activity following severe thermal injury
2019
·
R J Dinsdale
, J Hazeldine
, et al.
·
British journal of surgery
·
36
PDF
A prospective, phase II, single-centre, cross-sectional, randomised study investigating Dehydroepiandrosterone supplementation and its Profile in Trauma: ADaPT
2021
·
Conor Bentley
, Claire Potter
, et al.
·
BMJ Open
·
5
PDF
MIF mediates monocyte-dependent inhibition of natural killer cell cytotoxicity in triple-negative breast cancer
2026
·
Christos Ermogenous
, Marti Brucoli
, et al.
·
Cell Reports
·
1
Isolation of Live Immune Cells from the Tumor Microenvironment by FACS
2023
·
Aikaterini Kafka
, Christos Ermogenous
, et al.
·
Methods in molecular biology
·
1
Abstract B022: Investigating how monocytes impair NK cell cytotoxicity in lung metastasis of triple-negative breast cancer
2024
·
Christos Ermogenous
, Luigi Ombrato
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
81
H-index:
3
I10-index:
2
Year
Topic
Type